https://www.statnews.com/2025/11/13/uniqure-huntingtons-disease-investors-dinner/
Nov 13, 2025 - The company is hoping to find a way forward with an FDA submission of its gene therapy for Huntington's disease.
uniqureceodinedinvestors
https://www.macrotrends.net/stocks/charts/QURE/uniqure/roi
Current and historical return on investment (ROI) values for UniQure (QURE) over the last 10 years.
return on investmentuniqure
https://www.fool.com/investing/2023/06/21/why-uniqure-stock-is-crashing-today/
Investors are focusing on the negative parts of the biotech company's interim results.
the motley fooluniqurestockcrashingtoday
https://www.statnews.com/2025/09/24/huntingtons-gene-therapy-uniqure/
Sep 24, 2025 - Results are likely to support the first approval of a genetic treatment for the rare neurodegenerative condition.
gene therapydisease progressionuniqureslowedkey